Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation

Saurabh Chhabra, Ying Liu, Michael T. Hemmer, Luciano Costa, Joseph A. Pidala, Daniel R. Courie, Amin M. Alousi, Navneet S. Majhai, Robert K. Stuart, Dennis Kim, Olle Ringden, Alvaro Urbano-Ispizua, Ayman Saad, Bipin N. Savani, Brenda Cooper, David I. Marks, Gerard Socie, Harry C. Schouten, Helene Schoemans, Hisham Abdel-AzimJean Yared, Jean-Yves Cahn, John Wagner, Joseph H. Antin, Leo F. Verdonck, Leslie Lehmann, Mahmoud D. Aljurf, Margaret L. MacMillan, Mark R. Litzow, Melhem M. Solh, Muna Qayed, Peiman Hematti, Rammurti T. Kamble, Ravi Vij, Roberti Hayashi, Robert P. Gale, Rodrigo Martino, Sachiko Seo, Shahrukh K. Hashmi, Taiga Nishihori, Takanori Teshima, Usama Gergis, Yoshihiro Inamoto, Stephen R. Spellman, Mukta Arora*, Betty K. Hamilton

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)73-85
Number of pages13
JournalBiology of Blood and Marrow Transplantation
Volume25
Issue number1
DOIs
Publication statusPublished - Jan 2019

Keywords

  • Calcineurin inhibitor Tacrolimus
  • Cyclosporine
  • Methotrexate
  • Mycophenolate mofetil
  • Graft-versus-host disease prophylaxis
  • Reduced-intensity conditioning
  • Allogeneic hematopoietic cell transplantation
  • STEM-CELL TRANSPLANTATION
  • BONE-MARROW
  • COMPARING METHOTREXATE
  • GVHD PROPHYLAXIS
  • CYCLOSPORINE
  • BLOOD
  • TACROLIMUS
  • TRIAL

Cite this

Chhabra, S., Liu, Y., Hemmer, M. T., Costa, L., Pidala, J. A., Courie, D. R., Alousi, A. M., Majhai, N. S., Stuart, R. K., Kim, D., Ringden, O., Urbano-Ispizua, A., Saad, A., Savani, B. N., Cooper, B., Marks, D. I., Socie, G., Schouten, H. C., Schoemans, H., ... Hamilton, B. K. (2019). Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation. Biology of Blood and Marrow Transplantation, 25(1), 73-85. https://doi.org/10.1016/j.bbmt.2018.08.018